Showing results (1471-1480 of 6,769) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|August 18, 2020
Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy SubjectsHongjie Qian, Xue Wu, Qian Chen, et al.
Clinical Therapeutics|July 4, 2020
Comparative Cost-effectiveness of Aflibercept and Ramucirumab in Combination with Irinotecan and Fluorouracil-based Therapy for the Second-line Treatment of Metastatic Colorectal Cancer in JapanMunenobu Kashiwa, Ryo Matsushita
Clinical Therapeutics|March 12, 2015
Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipationJan Poelaert, Gineke Koopmans-Klein, Alioune Dioh, et al.
Clinical Therapeutics|June 28, 2020
Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health ServicePatrizio Armeni, Ludovica Borsoi, Giulia Fornaro, et al.
Clinical Therapeutics|January 26, 2015
Medication adherence and attrition to biologic treatment in rheumatoid arthritis patientsLi-Hao Chu, Aniket A Kawatkar, Sherine E Gabriel
Clinical Therapeutics|January 26, 2015
An assessment of the pharmacokinetics of a sustained-release formulation of a tramadol/acetaminophen combination in healthy subjectsYong-Jin Im, Ji-Young Jeon, Eun-Young Kim, et al.
Clinical Therapeutics|January 29, 2015
Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United KingdomXiting Cao, Flavia Ejzykowicz, Dena R Ramey, et al.
Clinical Therapeutics|July 3, 2014
Ultra-low-dose decitabine combined with autologous cytokine-induced killer cells for elderly patients with acute myeloid leukemia transformed from myelodysplastic syndromeHaitao Wang, Bo Yang, Xiaohua Chi, et al.
Clinical Therapeutics|July 3, 2014
Comparison of gemcitabine combined with targeted agent therapy versus gemcitabine monotherapy in the management of advanced pancreatic cancerQin Li, Zhenyan Yuan, Han Yan, et al.
Clinical Therapeutics|July 28, 2012
Development of a population-based cost-effectiveness model of chronic graft-versus-host disease in SpainCarlos Crespo, José Anton Pérez-Simón, José Manuel Rodríguez, et al.
Pageof 677